References analysis of the Wikipedia article "Apolipoprotein AI" in the English version

doi.org

Breslow JL, Ross D, McPherson J, Williams H, Kurnit D, Nussbaum AL, et al. (November 1982). "Isolation and characterization of cDNA clones for human apolipoprotein A-I". Proceedings of the National Academy of Sciences of the United States of America. 79 (22): 6861–6865. Bibcode:1982PNAS...79.6861B. doi:10.1073/pnas.79.22.6861. PMC 347233. PMID 6294659.

Arinami T, Hirano T, Kobayashi K, Yamanouchi Y, Hamaguchi H (June 1990). "Assignment of the apolipoprotein A-I gene to 11q23 based on RFLP in a case with a partial deletion of chromosome 11, del(11)(q23.3----qter)". Human Genetics. 85 (1): 39–40. doi:10.1007/BF00276323. PMID 1972696. S2CID 22613512.

Zong NC, Li H, Li H, Lam MP, Jimenez RC, Kim CS, et al. (October 2013). "Integration of cardiac proteome biology and medicine by a specialized knowledgebase". Circulation Research. 113 (9): 1043–1053. doi:10.1161/CIRCRESAHA.113.301151. PMC 4076475. PMID 23965338.

van der Vorst EP (2020). "High-Density Lipoproteins and Apolipoprotein A1". Vertebrate and Invertebrate Respiratory Proteins, Lipoproteins and other Body Fluid Proteins. Subcellular Biochemistry. Vol. 94. pp. 399–420. doi:10.1007/978-3-030-41769-7_16. ISBN 978-3-030-41768-0. PMID 32189309. S2CID 213180689.

Wasan KM, Brocks DR, Lee SD, Sachs-Barrable K, Thornton SJ (January 2008). "Impact of lipoproteins on the biological activity and disposition of hydrophobic drugs: implications for drug discovery". Nature Reviews. Drug Discovery. 7 (1): 84–99. doi:10.1038/nrd2353. PMID 18079757. S2CID 1989187.

Yui Y, Aoyama T, Morishita H, Takahashi M, Takatsu Y, Kawai C (September 1988). "Serum prostacyclin stabilizing factor is identical to apolipoprotein A-I (Apo A-I). A novel function of Apo A-I". The Journal of Clinical Investigation. 82 (3): 803–807. doi:10.1172/JCI113682. PMC 303586. PMID 3047170.

McQueen MJ, Hawken S, Wang X, Ounpuu S, Sniderman A, Probstfield J, et al. (July 2008). "Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study". Lancet. 372 (9634): 224–233. doi:10.1016/S0140-6736(08)61076-4. PMID 18640459. S2CID 26567691.

Shelby ML, He W, Dang AT, Kuhl TL, Coleman MA (3 July 2019). "Cell-Free Co-Translational Approaches for Producing Mammalian Receptors: Expanding the Cell-Free Expression Toolbox Using Nanolipoproteins". Frontiers in Pharmacology. 10. Frontiers Media SA: 744. doi:10.3389/fphar.2019.00744. PMC 6616253. PMID 31333463.

Dastani Z, Dangoisse C, Boucher B, Desbiens K, Krimbou L, Dufour R, et al. (March 2006). "A novel nonsense apolipoprotein A-I mutation (apoA-I(E136X)) causes low HDL cholesterol in French Canadians". Atherosclerosis. 185 (1): 127–136. doi:10.1016/j.atherosclerosis.2005.05.028. PMID 16023124.

Yamakawa-Kobayashi K, Yanagi H, Fukayama H, Hirano C, Shimakura Y, Yamamoto N, et al. (February 1999). "Frequent occurrence of hypoalphalipoproteinemia due to mutant apolipoprotein A-I gene in the population: a population-based survey". Human Molecular Genetics. 8 (2): 331–336. doi:10.1093/hmg/8.2.331. PMID 9931341.

Franceschini G, Sirtori M, Gianfranceschi G, Sirtori CR (May 1981). "Relation between the HDL apoproteins and AI isoproteins in subjects with the AIMilano abnormality". Metabolism. 30 (5): 502–509. doi:10.1016/0026-0495(81)90188-8. PMID 6785551.

Zhu X, Wu G, Zeng W, Xue H, Chen B (June 2005). "Cysteine mutants of human apolipoprotein A-I: a study of secondary structural and functional properties". Journal of Lipid Research. 46 (6): 1303–1311. doi:10.1194/jlr.M400401-JLR200. PMID 15805548.

Chiesa G, Sirtori CR (April 2003). "Apolipoprotein A-I(Milano): current perspectives". Current Opinion in Lipidology. 14 (2): 159–163. doi:10.1097/00041433-200304000-00007. PMID 12642784. S2CID 75941726.

Nissen SE, Tsunoda T, Tuzcu EM, Schoenhagen P, Cooper CJ, Yasin M, et al. (November 2003). "Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial". JAMA. 290 (17): 2292–2300. doi:10.1001/jama.290.17.2292. PMID 14600188.

Singh P, Singh M, Kaur TP, Grewal SS (November 2008). "A novel haplotype in ApoAI-CIII-AIV gene region is detrimental to Northwest Indians with coronary heart disease". International Journal of Cardiology. 130 (3): e93–e95. doi:10.1016/j.ijcard.2007.07.029. PMID 17825930.

Singh P, Singh M, Gaur S, Kaur T (June 2007). "The ApoAI-CIII-AIV gene cluster and its relation to lipid levels in type 2 diabetes mellitus and coronary heart disease: determination of a novel susceptible haplotype". Diabetes & Vascular Disease Research. 4 (2): 124–129. doi:10.3132/dvdr.2007.030. PMID 17654446. S2CID 23793589.

Vollbach H, Heun R, Morris CM, Edwardson JA, McKeith IG, Jessen F, et al. (September 2005). "APOA1 polymorphism influences risk for early-onset nonfamiliar AD". Annals of Neurology. 58 (3): 436–441. doi:10.1002/ana.20593. PMID 16130094. S2CID 42148248.

Maezawa I, Jin LW, Woltjer RL, Maeda N, Martin GM, Montine TJ, et al. (December 2004). "Apolipoprotein E isoforms and apolipoprotein AI protect from amyloid precursor protein carboxy terminal fragment-associated cytotoxicity". Journal of Neurochemistry. 91 (6): 1312–1321. doi:10.1111/j.1471-4159.2004.02818.x. PMID 15584908. S2CID 30014992.

Solomon A, Murphy CL, Kestler D, Coriu D, Weiss DT, Makovitzky J, et al. (November 2006). "Amyloid contained in the knee joint meniscus is formed from apolipoprotein A-I". Arthritis and Rheumatism. 54 (11): 3545–3550. doi:10.1002/art.22201. PMID 17075859.

Ma J, Liao XL, Lou B, Wu MP (June 2004). "Role of apolipoprotein A-I in protecting against endotoxin toxicity". Acta Biochimica et Biophysica Sinica. 36 (6): 419–424. doi:10.1093/abbs/36.6.419. PMID 15188057.

Huang JT, Wang L, Prabakaran S, Wengenroth M, Lockstone HE, Koethe D, et al. (December 2008). "Independent protein-profiling studies show a decrease in apolipoprotein A1 levels in schizophrenia CSF, brain and peripheral tissues". Molecular Psychiatry. 13 (12): 1118–1128. doi:10.1038/sj.mp.4002108. PMID 17938634. S2CID 5576909.

Singh P, Singh M, Kaur T (May 2009). "Role of apolipoproteins E and A-I: epistatic villains of triglyceride mediation in coronary heart disease". International Journal of Cardiology. 134 (3): 410–412. doi:10.1016/j.ijcard.2007.12.102. PMID 18378026.

Wehmeier K, Beers A, Haas MJ, Wong NC, Steinmeyer A, Zugel U, et al. (October 2005). "Inhibition of apolipoprotein AI gene expression by 1, 25-dihydroxyvitamin D3". Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1737 (1): 16–26. doi:10.1016/j.bbalip.2005.09.004. PMID 16236546.

Lahoz C, Peña R, Mostaza JM, Jiménez J, Subirats E, Pintó X, et al. (June 2003). "Apo A-I promoter polymorphism influences basal HDL-cholesterol and its response to pravastatin therapy". Atherosclerosis. 168 (2): 289–295. doi:10.1016/S0021-9150(03)00094-7. PMID 12801612.

Fitzgerald ML, Morris AL, Rhee JS, Andersson LP, Mendez AJ, Freeman MW (September 2002). "Naturally occurring mutations in the largest extracellular loops of ABCA1 can disrupt its direct interaction with apolipoprotein A-I". The Journal of Biological Chemistry. 277 (36): 33178–33187. doi:10.1074/jbc.M204996200. PMID 12084722.

Deeg MA, Bierman EL, Cheung MC (March 2001). "GPI-specific phospholipase D associates with an apoA-I- and apoA-IV-containing complex". Journal of Lipid Research. 42 (3): 442–451. doi:10.1016/S0022-2275(20)31669-2. PMID 11254757.

Pussinen PJ, Jauhiainen M, Metso J, Pyle LE, Marcel YL, Fidge NH, et al. (January 1998). "Binding of phospholipid transfer protein (PLTP) to apolipoproteins A-I and A-II: location of a PLTP binding domain in the amino terminal region of apoA-I". Journal of Lipid Research. 39 (1): 152–161. doi:10.1016/S0022-2275(20)34211-5. PMID 9469594.

harvard.edu

ui.adsabs.harvard.edu

nih.gov

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

semanticscholar.org

api.semanticscholar.org

web.archive.org

"Apolipoprotein A-IV". Cardiac Organellar Protein Atlas Knowledgebase (COPaKB). Archived from the original on 5 March 2016. Retrieved 25 March 2015.

"Apo A-I Milano". Cedars-Sinai Heart Institute. Archived from the original on 21 December 2007. Retrieved 26 July 2008.

"STRING: Known and Predicted Protein-Protein Interactions". Archived from the original on 18 July 2011.

wikipathways.org

The interactive pathway map can be edited at WikiPathways: "Statin_Pathway_WP430".

Apolipoprotein AI (English Wikipedia)

cedars-sinai.edu

clevelandclinic.org

doi.org

embl.de

string.embl.de

ensembl.org

May2017.archive.ensembl.org